Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Antifungal agent that is used as a component of creams, gels, suspensions or pessaries.
At latest update no published data were found on excretion into breast milk.
Less than 5% of the applied dose is absorbed (SMI 2013, Medea 2010, Leachman 2006, Mactal 2001). Because the small dose used and low level achieved in the plasma of most topical dermatological preparations make unlikely the passage of significant amounts into breast milk.
Even more, its high plasma protein-binding capacity makes unlikely excretion into milk.
Do not apply on the breast to prevent infant ingestion; otherwise, apply it after a feeding and clean thoroughly with water before the next one.
It is advisable to avoid the application on the nipple of creams, gels and other products of local application containing kerosene (mineral oil) so that the infant does not absorb it. (Concin 2008, Noti 2003)